The latest news from Senzer

Please take some time to browse through our media section, Here, you’ll find Senzer’s latest and archived press releases, announcements and other media resources.

If you have any media-related enquiries please contact press@senzer.com.

News

Sep 25 2018
Senzer Limited - Logo
Senzer Logo
Senzer Limited
Press release

New Trial Data: Senzer’s Inhaler delivers cannabinoids faster at lower doses

The physical uptake of pharmaceutical cannabinoids when inhaled through Senzer’s unique respiratory device is more than 50 times faster than oral delivery, at just a fraction of the dose, according to data released today under a clinical trial conducted in the US. Senzer, a UK-based drug delivery company, reported the success of a 36-subject pharmacokinetic...

Read More
Jul 5 2018
Senzer Limited - Logo
Senzer Logo
Senzer Limited
Press release

Senzer plans to launch its first inhaled cannabinoid products in the UK

Senzer Ltd has announced that it intends to launch its inhaled cannabinoid portfolio of products later this year in the UK under a specials pharmaceutical licence. This would enable doctors to prescribe its inhaled cannabinoid products to cancer patients undergoing chemotherapy. “Our delivery technology is a first of its kind – a respiratory delivery system...

Read More
Jul 5 2018
Senzer Limited - Logo
Senzer Logo
Senzer Limited
Press release

FDA accepts Clinical Research Plan to explore Senzer’s Inhaler for Cancer Patients

LONDON, UK – The US Food and Drug Administration have accepted an application for a clinical development study on Dronabinol Inhalation using Senzer’s unique breath-actuated inhaler, progressing the Company’s US partner, INSYS Therapeutics, on its path for approval of the device as an innovative approach to help cancer patients, Senzer said (today).

Read More